$TDG
TransDigm Group INC
CIK:0001260221|SEC Filings
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions |
9 Months Ended | |
|---|---|---|
Jun. 27, 2026 |
Jun. 28, 2025 |
|
| OPERATING ACTIVITIES: | ||
| NET INCOME | $ 1,521 | $ 1,465 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation | 137 | 121 |
| Amortization of intangible assets and product certification costs | 187 | 150 |
| Amortization of debt issuance costs, original issue discount and premium | 35 | 28 |
| Gain on sale of businesses, net | 0 | (17) |
| Non-cash stock and deferred compensation expense | 118 | 124 |
| Deferred income taxes | (2) | (3) |
| Changes in assets/liabilities, net of effects from acquisitions and sales of businesses: | ||
| Trade accounts receivable | (126) | (126) |
| Inventories | (232) | (158) |
| Income taxes payable (receivable) | 14 | (101) |
| Other assets | (96) | (6) |
| Accounts payable | 7 | 1 |
| Accrued interest | 208 | 195 |
| Accrued and other liabilities | (80) | (142) |
| Net cash provided by operating activities | 1,691 | 1,531 |
| INVESTING ACTIVITIES: | ||
| Capital expenditures | (205) | (156) |
| Acquisition of businesses, net of cash acquired | (3,159) | (239) |
| Other investing transactions, net | (6) | 46 |
| Net cash used in investing activities | (3,370) | (349) |
| FINANCING ACTIVITIES: | ||
| Proceeds from exercise of stock options | 116 | 147 |
| Dividends and dividend equivalent payments | (59) | (4,396) |
| Repurchases of common stock | (1,807) | (500) |
| Proceeds from issuance of senior subordinated notes, net | 1,686 | 2,615 |
| Repayments of senior subordinated notes, net | 0 | (2,650) |
| Proceeds from term loans, net | 1,781 | 0 |
| Proceeds from trade receivable securitization facility, net | 0 | 163 |
| Repayment on term loans | (56) | (44) |
| Financing costs and other, net | (9) | (4) |
| Net cash provided by (used in) financing activities | 1,652 | (4,669) |
| EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | (8) | 18 |
| NET DECREASE IN CASH AND CASH EQUIVALENTS | (35) | (3,469) |
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 2,808 | 6,261 |
| CASH AND CASH EQUIVALENTS, END OF PERIOD | 2,773 | 2,792 |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||
| Cash paid during the period for interest, net | 1,210 | 908 |
| Cash paid during the period for income taxes, net of refunds | $ 451 | $ 504 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions |
Jun. 27, 2026 |
Sep. 30, 2025 |
|---|---|---|
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $ 2,773 | $ 2,808 |
| Trade accounts receivable—Net | 1,817 | 1,617 |
| Inventories—Net | 2,586 | 2,095 |
| Prepaid expenses and other | 595 | 492 |
| Total current assets | 7,771 | 7,012 |
| PROPERTY, PLANT AND EQUIPMENT—NET | 1,740 | 1,579 |
| Goodwill | 12,166 | 10,612 |
| OTHER INTANGIBLE ASSETS—NET | 4,724 | 3,454 |
| OTHER NON-CURRENT ASSETS | 353 | 252 |
| TOTAL ASSETS | 26,754 | 22,909 |
| CURRENT LIABILITIES: | ||
| Current portion of long-term debt | 139 | 124 |
| Short-term borrowings—trade receivable securitization facility | 725 | 724 |
| Accounts payable | 434 | 368 |
| Accrued and other current liabilities | 1,276 | 966 |
| Total current liabilities | 2,574 | 2,182 |
| LONG-TERM DEBT | 32,621 | 29,167 |
| DEFERRED INCOME TAXES | 729 | 759 |
| OTHER NON-CURRENT LIABILITIES | 549 | 480 |
| Total liabilities | 36,473 | 32,588 |
| REDEEMABLE NONCONTROLLING INTERESTS (“NCI”) | 81 | 0 |
| TD GROUP STOCKHOLDERS’ DEFICIT: | ||
| Common stock - $.01 par value; authorized 224,400,000 shares; issued 62,855,861 and 62,465,317 at June 27, 2026 and September 30, 2025, respectively | 1 | 1 |
| Additional paid-in capital | 3,377 | 3,135 |
| Accumulated deficit | (9,107) | (10,606) |
| Accumulated other comprehensive loss | (54) | (10) |
| Treasury stock, at cost; 7,586,058 and 6,089,675 shares at June 27, 2026 and September 30, 2025, respectively | 4,026 | 2,206 |
| Total TD Group stockholders’ deficit | (9,809) | (9,686) |
| NONCONTROLLING INTERESTS | 9 | 7 |
| Total stockholders’ deficit | (9,800) | (9,679) |
| TOTAL LIABILITIES, REDEEMABLE NCI AND STOCKHOLDERS’ DEFICIT | $ 26,754 | $ 22,909 |